✦ LIBER ✦

Therapeutic options in patients with early T stage and advanced N stage of tonsillar squamous cell carcinomas

✍ Scribed by Man Ki Chung; Young-Ik Son; Jae Keun Cho; Yoon Kyoung So; Seung Hoon Woo; Han-Sin Jeong; Chung-Hwan Baek

Book ID: 113835490
Publisher: SAGE Publications
Year: 2010
Tongue: English
Weight: 177 KB
Volume: 143
Category: Article
ISSN: 0194-5998
DOI: 10.1016/j.otohns.2010.06.914

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of Concurrent Chemoradiation on T

Impact of Concurrent Chemoradiation on T Cell Populations in Patients With Advanced-Stage Oropharyngeal Squamous Cell Carcinoma

✍ Lee, W.T.; Medinas, R.; Lee, J.H.; Sparks, S.; Brizel, D.M.; Esclamado, R.M.; Re 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Analysis of Death Certification in Patie

Analysis of Death Certification in Patients With Early Stage Oral Cavity Squamous Cell Carcinoma

✍ Deepak Kademani; Evre Baltlai; Jason Lewis; Eugene Keller 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 684 KB

Pharmacodynamic evaluation of temsirolim

Pharmacodynamic evaluation of temsirolimus in patients with newly diagnosed advanced-stage head and neck squamous cell carcinoma

✍ Oleksandr Ekshyyan; Glenn M. Mills; Timothy Lian; Nazanin Amirghahari; Xiaohua R 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB 👁 1 views

## Abstract ## Background: Activation of the mammalian target of rapamycin (mTOR) pathway in surgical margins of head and neck squamous cell carcinoma (HNSCC) is a predictor of recurrence and patients with minimal residual disease may benefit from adjuvant therapy with temsirolimus, an mTOR inhibi

Metachronous second primary tumours in t

Metachronous second primary tumours in the aerodigestive tract in patients with early stage head and neck squamous cell carcinomas

✍ Xavier León; María del Prado Venegas; César Orús; Kasia Kolañczak; Jacinto Garcí 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 212 KB

A study of phosphorylated ERK1/2 and COX

A study of phosphorylated ERK1/2 and COX-2 in early stage (T1–T2) oral squamous cell carcinomas

✍ Tine M. Søland; Camilla Husvik; Hanna Strømme Koppang; Morten Boysen; Leiv Sandv 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 469 KB

Stage I (t1 N0 M0) squamous cell carcino

Stage I (t1 N0 M0) squamous cell carcinoma of the laryngeal glottis: Therapeutic results and voice preservation

✍ J. Gershon Spector; Donald G. Sessions; K. S. Clifford Chao; Bruce H. Haughey; J 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB 👁 2 views

Background. The therapeutic outcomes for voice preservation in Stage I (T1 N0 M0) glottic carcinoma, treated with conservation surgery, radiation therapy, and endoscopic resection, are controversial. Methods. A retrospective tumor registry retrieval of data on patients treated with curative intent